Long-term, regular aspirin use linked to lower colorectal cancer mortality

Long-term, regular use of aspirin before diagnosis appeared associated with lower colorectal cancer-specific mortality, according to results of an observational study published in Journal of the National Cancer Institute.Peter Campbell, MSc, PhD, scientific director in the department of population science at American Cancer Society, and colleagues pursued the research, in part, because one study published last year suggested increased colorectal cancer mortality with aspirin use. Additionally, they wanted to help health care providers and colorectal cancer survivors make educated decisionsRead More

Share on facebook
Share on twitter
Share on linkedin